Patents by Inventor Lukas Zeisel

Lukas Zeisel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISULFIDE-BASED PRODRUG COMPOUND
    Publication number: 20240207414
    Abstract: The present application relates to a compound having the formula (I); A-L-B (I) wherein A is represented by; L is a bond or a self-immolative spacer; B is represented by; The compound is capable of releasing molecular cargo in the presence of a reductase and is thus suitable for treating, ameliorating, preventing or diagnosing a disorder selected from a neoplastic disorder; atherosclerosis; an autoimmune disorder; an inflammatory disease; a chronic inflammatory autoimmune disease; ischaemia; and reperfusion injury.
    Type: Application
    Filed: March 22, 2022
    Publication date: June 27, 2024
    Applicant: Ludwig-Maximilians-Universitat Munchen
    Inventors: Julia Thorn-Seshold, Jan Felber, Lukas Zeisel, Oliver Thorn-Seshold
  • DICHALCOGENIDE PRODRUGS
    Publication number: 20240156965
    Abstract: The present application relates to a compound having the formula (I) A-L-B wherein A is represented by (AA), L is a bond or a self-immolative spacer; and B is represented by (BB) or (CC). The compound is capable of releasing molecular cargo in the presence of a reductase and is thus suitable for diagnosing or quantifying the activity of the reductase and for treating, ameliorating, preventing or diagnosing a disorder selected from a neoplastic disorder; atherosclerosis; an autoimmune disorder; an inflammatory disease; a chronic inflammatory autoimmune disease; ischaemia; and reperfusion injury.
    Type: Application
    Filed: April 7, 2022
    Publication date: May 16, 2024
    Applicant: Ludwig-Maximilians-Universitat Munchen
    Inventors: Oliver Thorn-Seshold, Lukas Zeisel, Jan Felber